Arvinas, a clinical-stage biotech company, announced it will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026. The company is known for developing VEPPANU, the first FDA-approved PROTAC drug for certain advanced breast cancers, in partnership with Pfizer. Arvinas is advancing multiple investigational drugs targeting diseases like neurodegenerative disorders, mutated cancers, and lymphoma. This presentation will showcase their innovative protein degradation platform and ongoing clinical programs, signaling potential growth and new treatment options.
STARLUX Airlines has introduced the AIRSORAYAMA Silver, the world's largest flying canvas, featuring a unique liquid-metal livery designed by Japanese artist Hajime Sorayama. The aircraft, an Airbus A350-1000, was unveiled in Toulouse and will be pil...
Netflix is seeing more viewers abandon shows before the second season, driven by frequent cancellations, long waits between seasons, and content tailored more for algorithms than storytelling. The streaming giant's binge model, once revolutionary aga...
Intertape Polymer Corp (IPG) has introduced a new PCR Air Pillow Film made with 50% recycled materials, including 35% post-consumer recycled content. This high-performance packaging film is designed to help companies meet sustainability goals without...
South Korea's Supreme Court has drafted new civil enforcement rules to legally freeze, seize, and liquidate virtual assets like bitcoin during civil litigation. These rules aim to prevent debtors from hiding cryptocurrency to avoid court judgments by...
Liquidity Services has named Karen Fascenda as its new Chief Human Resources Officer, effective July 6, 2026. Fascenda brings over 20 years of experience in human capital strategies from roles at Udemy, GoPuff, Comcast, and eBay. She replaces Novelet...
